AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimigard-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Astraea Life Sciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimigard-M1 Tablet SR

Diabeticard Duo, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This formulation combines two active components to regulate blood glucose. Consume Diabeticard Duo with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like kidney disease, vision impairment, neuropathy, and limb loss. Remember, Diabeticard Duo complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms such as sweating, dizziness, headache, and tremors, and carry a quick-acting glucose source (e.g., sugary snacks or juice). Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain is also possible. Do not use Diabeticard Duo if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your doctor of any heart conditions before commencing treatment; Diabeticard Duo may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood sugar monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimigard-M1 Tablet SR

No text was provided. Please provide the text you would like me to rephrase.

Uses of Glimigard-M1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimigard-M1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimigard-M1 Tablet SR should be administered with a meal.

Common Side effects of Glimigard-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigard-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimigard-M1 Tablet SR with a meal.

How Glimigard-M1 Tablet SR works:

Glimigard-M1 SR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimigard-M1 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimigard-M1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Consult your physician for advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Glimigard-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimigard-M1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Glimigard-M1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimigard-M1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced starting dose is typically recommended for individuals with mild to moderate hepatic dysfunction; however, it's contraindicated in those with severe liver disease.

What if you forget to take Glimigard-M1 Tablet SR :

Should you forget a dose of Glimigard-M1 SR Tablet, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimigard-M1 Tablet SR

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Glimigard-M1 Tablet SR

Retain this medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Glimigard-M1 Tablet SR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially dangerous side effect of metformin is particularly risky for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Glimigard-M1 Tablet SR and prompt medical attention.
Glimigard-M1 SR tablets contain glimepiride and metformin, employed in managing type 2 diabetes mellitus. This dual-therapy formulation enhances glycemic control in adult patients when coupled with dietary modification and physical activity. Glimepiride's mechanism involves stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose output and boosts insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes.
Glimigard-M1 SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headaches. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimigard-M1 Tablet SR use can indeed lead to Vitamin B12 deficiency. This medication impedes the stomach's absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological complications such as tingling and numbness in extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Glimigard-M1 SR tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimigard-M1 Tablet SR and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimigard-M1 Tablet SR
34
MRP 42
19% off